Investor Presentation

Oct 2018

2

Disclaimer

These slides have been prepared by Bomi Italia S.p.A. (“Bomi”, the “Company” and together with its subsidiaries the “Group”), solely for a presentation of the Company’s major economic drivers, without

any guarantee or representation, thus resulting in a mere estimation of the current and prospective results.

These slides are strictly confidential and are being shown to you solely for your information. Neither this document nor any copy thereof may be reproduced, further distributed to any other person or

published, in whole or in part, for any purpose. By attending this presentation, you are agreeing to be bound by these restrictions. Any failure to comply with these restrictions may constitute a violation of

applicable laws.

The information contained in this document (“Information”) has been provided by the Company or obtained from publicly available sources and has not been independently verified by BPER Banca

S.p.A. (“BPER”) nor from any other auditing firm.

None of the Company, BPER or any of their respective affiliates, directors, officers, advisers, agents or employees, nor any other person make any representation or warranty, express or implied, as to,

and no reliance should be placed on, the fairness, accuracy, materiality, completeness or correctness of the Information or any opinions contained herein. This presentation may contain financial

information and/or operating data and/or market information regarding the business, assets and liabilities of the Company and its subsidiaries and the results of operations and markets in which the

Company and its subsidiaries are active. Such financial information may not have been audited, reviewed or verified by any independent accounting firm and/or such operating or market information may

be based on management estimates or on reports prepared by third parties which neither the Company nor the BPER have independently verified. BPER has not made an independent evaluation or

appraisal of the business, assets or liabilities of the Company or any of its subsidiaries. It is not the intention of the Company or of BPER to provide, and you may not rely on these materials as providing,

a complete or comprehensive analysis of the Company’s financial or trading position or prospects. This presentation speaks as of its date and will not be updated. The Information included in this

presentation may be subject to updating, completion, revision and amendment and such Information may change materially without notice. No person is under any obligation to update or keep current

the Information contained in this presentation and any estimates, opinions and projections expressed relating thereto are subject to change without notice. Neither the Company or BPER, nor any of their

respective affiliates, directors, officers, advisers, agents or employees, nor any other person shall have any liability whatsoever (in negligence or otherwise) for any loss howsoever arising from any use

of these materials or its contents or otherwise arising in connection with this presentation. Any projections, estimates, forecasts, targets, prospects, returns and/or opinions contained in this presentation

involve elements of subjective judgment and analysis and are based upon the best judgment of the Company as of the date of this presentation. No representation or warranty is given as to the

achievement or reasonableness of, and no reliance should be placed on, any valuations, forecasts, estimates, opinions and projections contained in this presentation. In all cases, recipients should

conduct their own investigation and analysis on the Company and the Information contained in this presentation.

THIS PRESENTATION AND ANY RELATED ORAL PRESENTATION DOES NOT CONSTITUTE AN OFFER OR INVITATION TO SUBSCRIBE FOR, PURCHASE OR OTHERWISE ACQUIRE ANY

SECURITIES AND NOTHING CONTAINED HEREIN OR ITS PRESENTATION SHALL FORM THE BASIS OF ANY CONTRACT OR COMMITMENT WHATSOEVER. ANY DECISION TO PURCHASE

SECURITIES IN THE CONTEXT OF AN OFFERING SHOULD BE MADE ON THE BASIS OF INFORMATION CONTAINED IN THE ADMISSION DOCUMENT (DOCUMENTO DI AMMISSIONE) IN

ITALIAN LANGUAGE PUBLISHED IN RELATION TO SUCH AN OFFERING AND/OR ON THE FOLLOWING PRESS RELEASES, FINANCIAL REPORTS AND OTHER INFORMATIONS THAT HAD

BEEN ISSUED BY THE COMPANY, FROM ITS LISTING TO PRESENT DATE.

This Information contained in this document and any related presentations is being distributed to and is directed only at persons in Member States of the European Economic Area (“EEA”) who are

“qualified investors” within the meaning of Article 2(1)(e) of the Prospectus Directive (Directive 2003/71/ec) (“qualified investors”). Any person in the EEA who receives this document will be deemed to

have represented and agreed that it is a qualified investor. Any such recipient will also be deemed to have represented and agreed that it has not received this document on behalf of persons in the EEA

other than qualified investors or persons in the UK, Italy and other member states (where equivalent legislation exists) for whom the investor has authority to make decisions on a wholly discretionary

basis. The company, BPER and their affiliates, and others will rely upon the truth and accuracy of the foregoing representations and agreements. Any person in the EEA who is not a qualified investor

should not act or rely on this document or any of its contents. The Information contained in this document is not for publication, release or distribution in Australia, Canada or Japan. The distribution of

this document and any related presentation in other jurisdictions may be restricted by law and persons into whose possession this document or any related presentation comes should inform themselves

about, and observe, any such restriction. Any failure to comply with these restrictions may constitute a violation of the laws of any such other jurisdiction. This document may not be acted on or relied on

by persons who are not eligible to invest in securities offered. Any investment or investment activity to which this communication relates is available only to persons eligible to invest in securities and will

be engaged in only with such persons.

Agenda

1.0

2.0

3.0

3

About Bomi

Key Financials

Bomi Investment Opportunity

Our Vision 1.1

4

Strive to become the N°1 partner

to the Healthcare Industry.

Intelligence first,

Delivery after,

Customer Care always.

Bomi Group key drivers 1.2

5

Global

Presence

Customer

Loyalty

Beyond

Logistics

Bomi Group offers to its

multinational customers a

well-established

NETWORK COVERING

20 COUNTRIES,

managed by talented and

specialized teams.

Bomi focuses on a

HIGH-VALUE ADDED MARKET

that rewards strong compliance

with regulatory and

customized services.

This turns into remarkable

bluechip customer loyalty.

In addition to its Core Business Division,

Bomi Group offers a range of

CUSTOMIZED & INNOVATIVE SERVICES.

These include Home Care

Deliveries, Hospital Logistic Management

and Virtual Branch.

Global presence serving a growing market 1.3

6

Mediterranean:

Italy, Spain, Turkey

Northern Europe

France, Netherlands,

Russia

China North America:

US

South America:

Mexico, Argentina, Brasile,

Chile, Peru, Colombia,

Panama

APAC:

Singapore (HQ).

T World Medical Market: 423 mld USD

CAGR 16-21: +5,6%

China: +9,9%

APAC: +6,7%

LATAM: +9,1%

West EU: +6%

Source: BMI Research, Dec. 2017

More than 100 clients 1.4

7

Medical

Devices Implantables Chronic disease

treatments

In Vitro

Diagnostics

Pharma &

Food

supplements

Biotech

Home

Patients

Healthcare

Companies Hospitals Clinics Labs

Bomi cooperates with almost 90% of the most important multinational companies operating in

the Healthcare field, managing every kind of medical device and being involved in all the steps of

the healthcare supply chain.

1.5

8

Service portfolio

1.6

9

Service portfolio

Safe storage of any kind of healthcare product on behalf

of manufacturers in licensed, secure and monitored

locations under the strict observation of the quality

standards and local regulations.

• 40 Bomi Group warehouses worldwide

• 185.000 sqm of dedicated storage space.

• Ambient and controlled temperature warehouses

• Labelling & kitting activities

BOMI Health Carrier is the BOMI brand fully devoted to ambient and controlled temperature deliveries of Healthcare products, including emergency deliveries 24/7 of life-saving devices. • Deliveries to hospitals, home patients, pharmacies and laboratories.. • Leadership in the Home Care channel, addressed to the management of chronic disease.

1.7

10

Service portfolio

Value-added solutions – beyond standard logistic

services - to provide stable and long-lasting support to

our healthcare clients. Some examples are

Pharmaceutical Labs for the processing of secondary

packaging of pharma, food supplements and Virtual

Branch service (plug&play solutions to enter new

markets).

Since 2006, Bomi has been offering specific solutions for managing Hospital inventories, servicing both manufacturers and clinics, with the complete traceability of stock levels and reconciliation for the clients.

Strategic positioning: Bomi’s uniqueness 1.8

11

SP

EC

IAL

IZE

D

GE

NE

RA

LIS

T

LOCAL INTERNATIONAL

MIT (Dhl)

Due Torri

Fercam

Almacenar

Multipack

Shuttle

Ceva

UPS

DHL

FedEx

Kuehne + Nagel

Chiapparoli Logistica

AGV

Open Market

Andreani

Eurodifarm (Dhl)

Movianto

Xpo

Logista

Arvato (Bertelsmann)

In recent years there has been a steady M&A activity within the industry, as major generalist players

are willing to find vertical solutions to the healthcare sector.

Bomi’s other competitors are its potential customers, which can operate in the market using a

strategy of insourcing.

Market

trends Generalist

suppliers

Strategic approach Tactical approach

GE

NE

RA

LIS

T

SP

EC

IAL

IZE

D

Customer orientation

High levels of customization

Market-driven approach

Target: multinational

companies and industry

leaders

Global presence

1.9

12

A solid strategic path, with a view on MTA/Star

2014 Pre IPO

New activities in France,

Russia, Netherlands,

Peru, USA. Licencee in

China.

Issued a Pre-IPO

incentive bond of €1.5m

listed at segment

ExtraMot-Pro of Borsa

Italiana.

Got ELITE certificate

from Borsa Italiana

Bomi Group buys

80% of G. Carrai ,

becoming market

leader in Home

Care dialysis

deliveries in Italy,

and acquires Ritmo

Holding B.V, logistic

and transport

company in the

Netherlands

2015

30 years of activity.

Listing to the AIM

market Milan

2015

Bomi Group starts

operation

in Panama and

enters directly the

Chinese market.

Bomi Group creates

a new JV with

Distritec, French

Transport company

2016

Bomi acquires Logik

Trans Srl based in

Rome (June) and

Berga Srl based in

Modena (Oct.) to

strengthen its

transport network

2016

Bomi Group enters

directly the Mexican

market and

acquires the

remaining 20% of

G.Carrai

2017

Bomi Group

announces the

acquisition of the

minority stake in its

Brazilian subsidiary

2017

Bomi Group

acquires De Salute

Srl, a logistic player

specialized in the

pharmaceutical

sector and acquires

the remaining 20%

of Biocarrier and an

additional 10% of

Biomedical

Colombia

2018

Bomi Italia

announces two

important news into

the Articles: Loyalty

shares and

exemption from the

mandatory public

tender offer for

consolidation

effective from “step-

up” to the regulated

market.

2018

Bomi Italia

announces a share

capital increase of

up to Euro 4.99

million, successfully

completed, to reach

additional growth

and a Board

mandate to further

increase the share

capital for a

maximum total of

Euro 12 mln (within

five years).

2018

…NEXT STEP

MTA

MARKET…..

18 July 2018 - Bomi

Group announces

the acquisition of

Farma Logistica

S.r.l.

2018

Agenda 0.0

1.0

2.0

3.0

13

About Bomi

Key Financials

Bomi Investment Opportunity

Revenue Trend 2.1

14

Steady Historical Turnover growth, without M&A &

Newco, (CAGR ~ 10%) along the past 13 years,

despite the devaluation of the Brazilian real in recent

years.

Revenue composition balanced in the past 3 years,

thanks to the growth in Europe, resulting in a risk

mitigation in term of macro trends.

New Subsidiaries contribution is expected to increase

(in particular LATAM) 0,00

1,00

2,00

3,00

4,00

5,00

-

20.000

40.000

60.000

80.000

100.000

120.000

140.000

Bomi Group Sold Turnover Growth from M&A & Newco

Historical Turnover Avg Exc.Rate R$/€

Lineare (Historical Turnover)

The LATAM companies, at constant rate, increased their

revenues by 16% compared to first half 2017, mainly due

to organic growth.

Revenues in Europe increased by 25% compared to first

half 2017 due to De Salute company, acquired in January

2018.

49%

45%

4% 2%

1°st half 2018: Revenues by Region

Emea

Latam

Row

Apac

2018-06: lead indicators of Bomi Group results 2.2

15

Revenues rose by approx 5,9% compared to first half

2017. At constant rate 2017 revenues increased by

15% due to internal growth (about 6%) and the

inclusion in the consolidation area of De Salute

(about 9%).

Ebitda rose by approx 11,5% , at constant rate first

half 2017, compared to first half 2017.

Net earnings Bomi Group first half 2018 increased by

51%, at constant rate, compared to first half 2017,

The growth in net earnings Bomi Group is also

related to the strategy of consolidation of the

minorities.

+15% vs 2017

€ 6,3

€ 5,6 € 5,5

2

3

4

5

6

7

First half 2017 First Half 2018

Mio

EBITDA (constant exc.rate) EBITDA

0,00

0,20

0,40

0,60

0,80

1,00

1,20

1,40

1,60

1,80

30/06/2017 30/06/2018 30/06/2018 ex rate 2017

Net Earnings Net Earnings Bomi Group

€ 59 € 62 € 67

-6,0%

-1,0%

4,0%

9,0%

14,0%

€ -

€ 10

€ 20

€ 30

€ 40

€ 50

€ 60

€ 70

30/06/2017 30/06/2018 30/06/2018 ex rate

2017

Mio

Revenues Ebitda Margin

1° half 2018: NFP Bridge and Composition 2.3 OPERATIONAL

CASH FLOW

Cash-flow generated

from the operational

activity DELTA NWC Due to the growth of

revenues and

seasonality

M&A

primarily represented

by the acquisition of

De Salute and others

minorities

25,5

3,8 2,4 3,2

4,6 4,7 1,3 1,0

29,5

0,00

5,00

10,00

15,00

20,00

25,00

30,00

35,00

NFP 2017 Operational cash flow

Delta NWC Operative Investments

M&A Investments

Capital Increase

NFP Newco Others NFP 1st half 2018

Mili

on

i

CAPITAL

INCREASE

July 1°, 2018 Bomi

closed a Capital

Increase fully

subscribed

(35) (30) (25) (20) (15) (10) (5) 5 10 15 20 25 30 35 40

Cash & Equivalents

Short term Bank debts & Factors

Mid Term Loans

Leasing

Dividends due to minorities

Convertible Bond

Vendor Loan

Financial receivable

NFP BREAKDOWN

1° half 2018: Financial Debt payments plan 2.4

60,7

6,0

11,3

11,7

10,3

12,9

7,0 1,5

(32,3)

,00

10,00

20,00

30,00

40,00

50,00

60,00

70,00

0,00

10,00

20,00

30,00

40,00

50,00

60,00

70,00

No convertible financial debts

2018 II half 2.019 2.020 2.021 2.022 2.023 >= 2024 Cash and equivalent

Mili

on

i

NOTE: The payments due up to 2020 are fully covered by Cash and Equivalent presents at first half

2018.

Agenda 0.0

1.0

2.0

3.0

18

About Bomi

Key Financials

Bomi Investment Opportunity

To sum up 3.1

19

Strong customer loyalty

Increasing margins on a

growing Business Model

Market leadership in

Latin America & Italy

Multinational presence is a key winning factor.

Bomi Group has market leadership or co -

leadership in Brazil, Colombia, Peru and Italy and

a unique network to serve Latin America.

The recent new initiatives are starting to

show a postive EBITDA contribution

Present Company set-up has a remarkable

over capacity

Upside opportunities

through M&A activities

The potential business combination with a

high-margin target might result in outstanding

business perfomances

Bomi Group relatively low debt levels could fit

to a new development stage

The outstanding blue-chip customer loyalty

might generate cross-selling opportunities within

the Network

Strategic Milestones 3.2

20

Vertical Market

Consolidation

Game changing

acquisitions

Bomi 4.0

Focus on new acquisitions to increase

Bomi group vertical capabilities and scale

in present markets

- Robotics and Automation

- Go GREEN

- Innovative Services

- Remote Healthcare

Plan to identify a potential transformational

deal within 9-12 months thus activating the

€ 12million Capital Increase/Convertible

Bond upon decision of Bomi’s BoD

4€m

1€m

12€m

© Bomi Group Company, 2018

www.bomigroup.com